Table 4.
Antimicrobial agent | 2003–2004 (n = 1) |
2005–2006 (n = 8) |
2007–2008 (n = 3) |
2009–2010 (n = 7) |
2011–2012 (n = 14) |
2013–2014 (n = 15) |
---|---|---|---|---|---|---|
Amikacin | 0 | 25.0 | 0 | 14.3 | 14.3 | 0 |
Gentamicin | 0 | 25.0 | 33.3 | 42.9 | 28.6 | 13.3 |
Piperacillin | 0 | 37.5 | 66.7 | 28.6 | 15.4 | 14.3 |
Piperacillin/taazobactam | – | 20.0 | 66.7 | 28.6 | 21.4 | 0 |
Cefazolin | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
Cefuroxime | 100.0 | 100.0 | – | 100.0 | 100.0 | 100.0 |
Cefotaxime | – | 100.0 | 0 | 75.0 | 100.0 | 100.0 |
Ceftazidime | 0 | 12.5 | 66.7 | 14.3 | 14.3 | 6.7 |
Cefepime | – | 0 | 0 | 28.6 | 14.3 | 0 |
Cefoxitin | 100.0 | 100.0 | 100.0 | – | – | 100.0 |
Imipenem | 0 | 0 | 33.3 | 14.3 | 7.7 | 6.7 |
Meropenem | – | 0 | 50.0 | 66.7 | 27.3 | 0 |
Ciprofloxacin | 0 | 37.5 | 0 | 14.3 | 21.4 | 13.3 |